[心力衰竭的新节奏策略]
Sebastian E Beyer1, Guram Imnadze1, Philipp Sommer2,3
1Klinik für Elektrophysiologie, Herz- und Diabeteszentrum NRW, Ruhr Universität Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Deutschland.
Innere Medizin (Heidelberg, Germany)
|July 5, 2024
概括
左束枝节奏为心力衰竭患者提供了一个更有效的替代方案,比传统的心脏再同步治疗 (CRT) 更有效. 这种先进的技术改善了结果,应该被视为初始治疗策略.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 心脏再同步疗法 (CRT) 改善了心力衰竭患者的心脏功能障碍和左捆分支障碍的结果.
- 传统的通过冠状动脉鼻腔导向的CRT存在局限性,包括静脉接入问题,上升的门,以及显著的非响应率 (高达30%).
- 直接导电系统节奏,特别是左束分支节奏 (LBBP),提供了一种更生理的方法.
研究的目的:
- 评估左束分支节奏 (LBBP) 的有效性和安全性,作为传统CRT的替代方案.
- 在患有特定心脏病的患者中,将LBBP与标准CRT进行比较.
主要方法:
- LBBP涉及将左捆分支通过向右心室和深入心室间隔膜中推进一个进行节奏.
- 利用观察性研究和小型随机试验来评估结果.
主要成果:
- 由于左捆分支的广泛目标区域,LBBP的成功率很高 (>90%).
- 研究表明,与基于冠状动脉鼻腔的CRT相比,LBBP导致更大的QRS持续时间缩短,更好的静心功能和更低的心力衰竭住院率.
- 这些发现得到了初始随机试验数据的支持.
结论:
- 左束枝节奏是心脏再同步的高效技术.
- 应该考虑LBBP不仅作为救援疗法,而且越来越多地作为符合条件的患者的主要节奏策略.
- 预计大型随机试验的进一步结果将巩固LBBP在临床实践中的作用.
更多相关视频
相关概念视频
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:26Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:22Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362